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Materials and Methods 
Molecular Cloning  
All constructs were designed using circular polymerase extension cloning (CPEC) (37), 
restriction cloning, and gBlock gene fragments (Integrated DNA Technologies). Sequences 
coding for a hemagglutinin (HA) cleavable secretion motif and a FLAG epitope were placed at 
the 5’-end of the construct as in (23). HindIII and NotI cut sites were placed at the 5’- and 3’-
end, respectively, for cloning into pEGFP-N1 (Addgene) to generate all pCMV constructs. 
BamHI and HindIII sites were introduced via PCR for final subcloning onto pAAV.hSynapsin1 
and pAAV.CAG vectors. 
To maximize coupling between conformational changes and chromophore fluorescence, we 
chose to use a cpGFP module (LSS-LE-cpGFP-LP-DQL) from GCaMP6 (18) for insertion into 
DRD1 via CPEC. For screening linker variants, we generated a linker library by first creating an 
insert DNA carrying a 2 aminoacid-long randomized linker on each side of cpGFP (LSS-xx-
cpGFP-xx-DQL). Single colonies were manually picked and grown overnight as described in 
(38). All sensor sequences generated in this study are listed in the Supplementary Data S1 file. 
 
Structural modeling and sequence alignments 
Sequence alignments were performed using Jalview software (UK) (39) using a percentage 
identity color map. Inactive conformation of the sensor was predicted with rosetta_cm protocol 
of rosetta 3 (version 2015.31) (40). Primary sequence of sensor design was threaded with partial 
thread routine onto template PDB structures of inactive β2 adrenergic receptor (41) (ID: 2RH1) 
and unbound state of GCaMP3 (42) (ID: 4IK3). The threaded structures were then hybridized 
together with rosetta_cm protocol for membrane protein (43). A total of 374 PDB structures 
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were generated by rosetta_script routine. Structure with lowest total score was considered the 
final model. 
 
Cell culture, imaging and quantification 
HEK293T cells (ATCC #1573) and U2OS cells (ATCC #HTB-96) used in this study we 
cultured and transfected as in (23, 44). Primary hippocampal neurons were freshly isolated as 
previously described (45). Neurons were infected using AAVs (1 x 109 GC/ml) at DIV5, two 
weeks prior to imaging. Prior to imaging, cells were washed with HBSS (Life Technologies). 
Cell imaging was performed using a 40X oil-based objective on an inverted Zeiss Observer 
LSN710 confocal microscope with 488/513 ex/em wavelengths. For testing sensor responses, 
neurotransmitters/drugs were directly applied to the bath during the imaging session. For 
neurotransmitter titrations, a dual buffer gravity-driven perfusion system was used to exchange 
buffers between different drug concentrations. Surface labeling was achieved as described 
previously (23, 44). One-photon emission spectrum for the sensors was dertermined using the 
lambda-scan function of the confocal microscope. Two-photon emission spectrum was obtained 
with a 40X water-based objective on a SliceScope (Scientifica) and was used to obtain the 
normalized two-photon cross-section using a custom-made script on MATLAB. For ROIs 
selection, masks were generated either on the cell membrane or around the cytosol, depending on 
the experiment, using the threshold function in Fiji. We calculated spatial movies and images of 
ΔF/F in response to an applied ligand as 𝐹(𝑡) −	𝐹'()*+,,-.+ 𝐹'()*+,-.+/  with 𝐹(𝑡) the pixel-wise 
fluorescence value at each time, t, and mean fluorescence in time points prior to ligand 
application, 𝐹'()*+,-.+ . To avoid the possibility of infinite pixel values, we added a small offset to 
each pixel in 𝐹'()*+,-.+ . Based on the ΔF/F maps, we calculated a corresponding SNR map as 
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∆𝐹 𝐹	 ×	2𝐹'()*+,-.+⁄ . ΔFF heatmaps were generated using a custom MATLAB script. Surface 
expression of sensors was quantified as the ratio of membrane fluorescence over cytoplasm 
fluorescence. For titration curves, Kd values were obtained by fitting the data with a Hill 
function on Igor Pro (WaveMetrics). 
 
Dopamine-uncaging 
Uncaging experiments on neuronal dendrites were performed in the presence of 100 µM 
caged-dopamine (carboxynitroveratryl-DA, CNV-DA (46)) in the HBSS. Optical recordings 
were performed at 153 ms/frame scan rate. Uncaging was achieved by shining 405 nm light 
(40% laser power) on a 2 µm wide circular region selected 10 µm away from the dendrite 
surface.  
 
Internalization assay with flow cytometry 
24 hours post transfection, cells were re-plated onto 6 well dishes. The following day, 
surface levels of receptors were assayed by addition of Alexa-647-conjugated M1 antibody 
(Sigma) for 45 minutes, as described previously (23). Fluorescence intensity profiles of cells 
populations (>5000 cells) were measured using a FACS-Calibur instrument (BD Biosciences). 
Each condition was performed in duplicate. Internalization was calculated by measuring the 
fraction of surface fluorescence remaining after 30 minutes of 1 µM SKF81297 (Tocris) and 
divided by the non-treated condition. 
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Luminescence-based cAMP assay 
Experiments were conducted as previously described (23). Briefly, cells were transfected 
with the cyclic-permuted luciferase pGLOSensor-20F plasmid (Promega) and then treated with 
luciferin (GoldBio) in phenol and serum free media for 1 hour in a 24 well dish. Luminescence 
values for SKF81297 (Tocris) treated conditions were measured at their peaks and normalized 
with reference to 10 µM forskolin (Sigma) at its peak. 
 
Total Internal Reflection Fluorescence Microscopy (TIRF-FM) Live Imaging. 
Live cell TIRF-FM was conducted with a Nikon Ti-E inverted microscope at 37°C in a 
controlled humidity and CO2 controlled chamber as described previously (23). D1 specific 
agonist SKF81297 (Tocris) was added at 1 µM while D1 antagonist SCH23390 (Tocris) was 
added at 10 µM. 
 
Preparation and transfection of cortical organotypic slice cultures  
Rat hippocampal slice cultures were prepared from P6 – P7 pups as previously described 
(47, 48). pCMV-dLight1.2 (12µg) and pCMV-mCherry (3µg) were mixed with single cell 
electroporation solution (160 mM NaCl ,  5.4 mM KCl, 12mM MgCl2,  2 mM CaCl2 , 5 mM 
HEPES,  pH 7.4 ) to total volume of 36 µl. One-week old hippocampal cultured slices were 
transfected with single cell electroporation (49). 5 – 7 days after transfection, single 
hippocampal cultured slice was transferred to the imaging chamber in a custom built two-
photon imaging setup. Slices were perfused in 10ml gassed artificial cerebral spinal fluid 
(ACSF) containing 4mM Ca2+, 4mM Mg2+, 0.5 µM TTX and 10µM cocaine (DA transporter 
blocker) during imaging. 
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AAV viral production 
All dLight1 AAV constructs were cloned in the laboratory, and viruses were produced by the UC 
Davis Vision Center Vector Design and Packaging Core facility. The viral titers of the viruses 
used in this study were: AAV1.CAG.flex.tdTomato, ~8 x 1012 genome copies (GC)/mL 
(University of Pennsylvania); AAV5.hSynapsin1.flex.ChrimsonR.tdTomato, ~4 x 1012 GC/mL 
(University of North Carolina); AAV1. hSynapsin1.NES-jRGECO1a, ~3 x 1013 GC/mL 
(University of Pennsylvania); AAV1. hSynapsin1.dLight1.1, ~1 x 1012 GC/mL; AAV1. 
hSynapsin1.dLight1.2, ~2 x 1012 GC/mL; AAV9. hSynapsin1.dLight1.2, ~4 × 1012 GC/mL; 
AAV9.CAG.dLight1.1, ~7 × 1011 GC/mL; AAV9.CAG.control_sensor, ~1 x 1012 GC/mL. 
 
Animals 
Animal studies were conducted in compliance with the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of California, Davis or the relevant 
institutional regulatory body. Wild type rats were used in this study (0-2 months old) for 
neuronal and organotypic slice culture preparation and two-photon imaging in brain slice. 
Dopamine receptor-D1 (Drd1)-Cre mice (4-6 months old, Jackson Labs, Strain B6; 129-
Tg(Drd1-cre)120Mxu/MMJax) were used for two-photon imaging in the dorsal striatum. 
Vesicular GABA transporter (VGAT)::IRES-Cre (50) (Jackson Labs, Slc32a1tm2(cre)Lowl/J) 
and Tyrosine hydroxylase (TH)::IRES-Cre (51) (Jackson Labs, B6.129X1-Thtm1(cre)Te/Kieg) 
knock-in mice between 3 and 5 months old were used for in vivo imaging using fiber photometry 
and for optogenetic manipulations. Wild type male mice (2 to 5 months old, C57BL6/J, Jackson 
Laboratories) were used for two-photon in vivo imaging in the cortex. Sample sizes (number of 
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mice) for each experiment are stated in main text. All animals were group housed in standard 
plastic cages on a 12-hour light/dark cycle with food and water available ad libitum, except for 
mice trained on the visuomotor association task (see below). These mice were house individually 
on a reverse 12-hour light/dark cycle. Anesthesia was performed with 4.5% isoflurane for 
induction and 2% for maintenance. 
 
Viral injections  
Injection procedures were essentially identical to those described in (10, 52-54) with a few 
exceptions.  
For dopamine imaging in brain slice, male and female Sprague-Dawley rats (p23-27) were 
used for intracerebral microinjections. Briefly, anesthetized rats were immobilized in a 
Stereotaxic Alignment System (Kopf Instruments). AAV1.hSynapsin1.dLight1.2 (200 nl) was 
injected uni-laterally into the dorsal striatum using the following coordinates from bregma (in 
mm): 0.48 anteroposterior (AP), ±2.19 mediolateral (ML), 4.69 dorsoventral (DV). 
For dopamine imaging in the dorsal striatum, mice were injected in the dorsal striatum at 
two caudal locations (+0.6 and +0.2 AP and 2.1mm ML to bregma) and 3 depths below the 
surface (-1.6mm, -1.9mm, and -2.2mm; 100 nL at each depth, total 0.6uL) with either AAV1. 
hSynapsin1.dLight1.1 or AAV1. hSynapsin1.dLight1.2 in combination with 
AAV1.CAG.flex.tdTomato (diluted 1:100 in PBS). The flex-tdTomato in our experiments is 
expressed in roughly half of the SPNs (Drd1-cre mice) to avoid potential issues, such as 
competition of expression when two AAVs are co-expressed in the same neurons.  
For dopamine imaging using fiber photometry, AAV9.CAG.dLight1.1 or 
AAV9.CAG.control_sensor were injected into the NAc (+1.3 mm AP, -1.25 mm ML, -4.25 
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mm DV) and cre-dependent AAV encoding ChrimsonR-tdTomato was injected into the VTA 
(-3.3 mm AP, -0.5 mm ML, -4.3 mm DV). For dual color photometry experiments, AAV 
encoding jRGECO1a was 1:1 mixed with dLight1.1 virus and injected into the NAc region 
(+1.3 mm AP, -1.5 mm ML, -4.25 mm DV). A 10 µL NanoFil microsyringe (World Precision 
Instruments) with a blunt 35-gauge needle was used for viral injection and manipulated by a 
microsyringe pump (UMP3, World Precision Instruments) and a controller (Micro4, World 
Precision Instruments). 500 nL of AAV was slowly injected into the target coordinates over 
10 minutes, and additional 10 minutes were waited to allow diffusion. The needle was slowly 
withdrawn over 10-15 minutes. 
For dopamine imaging in the cortex, anesthetized animals (4% isoflurane for induction; 
~1.5% during surgery) were positioned in a computer-assisted stereotactic frame with digital 
coordinate readout and atlas targeting (Angle Two, Leica Biosystems Inc., Buffalo Grove, 
IL). Micropipettes were loaded with virus solution and slowly lowered into the brain under a 
~32º injection angle until the target depth (~0.2 mm) was reached. Manual pressure was applied 
to a 30 mL syringe connected to the injection pipette. Virus solution was slowly injected over a 
period of 5–10 min. Once desired injection volume (200-400 nl) was delivered, the syringe’s 
pressure valve was locked and position maintained for approximately 10 min to allow virus to 
spread and to avoid backflow upon needle retraction. Each mouse received two injections of 
AAV9. hSynapsin1.dLight1.2 (1:50 dilution). Injection coordinates were (AP 3-3.2 mm, ML 1-
1.2 mm) and (AP 1.5 mm, ML 1-1.5 mm). 
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Slice preparation  
5% isoflurane was used to deeply anesthetize rats prior to decapitation. Brains were rapidly 
removed and placed in modified Krebs buffer containing (in mM) 126 NaCl, 2.5 KCl, 1.2 
MgCl2, 2.4 CaCl2, 1.4 NaH2PO4, 25 NaHCO3, 11 D-glucose, and with 10 µM MK-801. 
Horizontal slices (245 µm) were taken using a Leica vibratome and allowed to recover for at 
least 30 minutes prior to use in Krebs with MK-801 being continuously bubbled with 95/5% 
O2/CO2. Slicing and recovery was done at elevated temperatures (30-34° C). Following recovery, 
slices were secured in a recording chamber maintained at 34° C and perfused with modified 
Krebs at a rate of 3 ml/min. 
 
Surgical procedures for in vivo imaging 
Cannula implant for in vivo imaging in dorsal striatum 
Two weeks post-injection, a chronic imaging window was implanted over the external 
capsule fibers above the striatal injection site as described previously (10).  Briefly, a 2.75mm 
craniotomy was performed on anaesthetized mice, and cortical tissue was slowly aspirated until 
the white matter of the external capsule was exposed. A thin layer of Kwik-Sil (WPI) was 
applied over the imaging region, and a metal cannula covered at one end by a glass coverslip was 
inserted into the aspiration site down to the fiber surface. 
 
Optical fiber implantation for fiber photometry and optogenetics 
Mice were anesthetized with isoflurane and carbogen mixture (4-5% for induction, 1.5-
2% for maintenance) and carefully placed to a stereotaxic frame (Kopf Instruments) after 
shaving their hair. Head skin was sterilized with chlorohexidine and a midline incision was 
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made using a sterile scalpel. The skull surface was exposed and cleaned with sterilized cotton 
swabs. Bregma and lambda points were identified and leveled to be at the same dorsal-ventral 
axis. Small craniotomy holes were made with drill bits (#73 size, Kyocera) over the nucleus 
accumbens (NAc) and ventral tegmental area (VTA). After viral delivery, optical ferrule/fiber 
(for VTA/optogenetics, 300 µm diameter, 5-6 mm cut length, NA 0.37, home-made; for 
NAc/photometry, 400 µm diameter, 5 mm cut length, NA 0.48, Doric lenses) was mounted to 
a stereotaxic cannula holder (Doric lenses). First, a 400 µm fiber was lowered to the NAc 
through a craniotomy hole and stopped at 200 µm above the virus injection target. A layer of 
adhesive cement (C&B Metabond, Parkell Inc.) was applied to the anterior portion of skull 
surface to strongly hold the implanted ferrule. Care was taken not to apply Metabond near the 
posterior craniotomy sites for VTA. Next, a 300 µm fiber was inserted to the VTA and 
stopped at 500 µm above the injection site. Another layer of adhesive cement was applied to 
hold the second fiber. After adhesive cement was fully dried, a thick layer of dental cement 
(Lang Dental) was applied to build a head cap. 
 
Head plate and cranial window implantation for in vivo imaging in the cortex.  
A few weeks after viral injections, mice were implanted with a head plate and cranial 
window on a custom surgical bed (Thorlabs Inc., Newton, NJ). Body temperature was 
maintained at 36–37 °C with a DC temperature control system and ophthalmic ointment was 
used to prevent eyes from drying. Skin was cleaned and disinfected with 70% ethanol and 
Betadine. A small (~10 mm) incision was performed along the midline. The scalp was pulled 
open and periosteum cleaned. First, a portion of the scalp was surgically removed to expose 
frontal, parietal, and interparietal skull segments. Then, the metal plate was affixed to the 
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bone with C&B Metabond Quick Adhesive Cement (Parkell Inc., Edgewood, NY). Next, to 
enable chronic two-photon imaging, a custom-made cranial window was implanted, similar to 
(55). The craniotomy (2.5 mm diameter) was centered around (AP 2 mm and ML 1.5 mm) and 
sealed with a custom three-layered cover glass assembly (each No.1 thickness) with the two 
layers closest to the cortex consisting of two pieces of circular 2.5 mm-diameter cover glass 
and the outermost layer consisting of a circular 4 mm-diameter cover glass that rested on the 
thinned skull. The dura mater was kept intact. 
 
Behavioral experiments 
Sucrose consumption 
Mice were handled daily for 5-10 minutes to reduce anxiety associated with 
experimenter’s handling. Following recovery from surgery (~7 days) mice were water-
restricted to 1.5 mL per day and maintained at 85-90 % of ad libitum weight. All behavioral 
experiments were carried out in an operant chamber within a sound-attenuating box (Lafayette 
Instruments). Behavioral tasks were implemented and controlled by ABET II software 
(Lafayette Instruments). TTL pulses were used to synchronize with fiber photometry 
recordings. After at least 7 days of water deprivation, mice were introduced to an operant 
chamber and allowed to freely explore with a patch cord connected. 50 µL of 5 % sucrose 
water was delivered every 60 seconds (total 10 times) so that mice can learn the position of a 
lick port. Lick was detected as a break of infrared beam at the lick port. This habituation 
session was repeated two to three times for each mouse until they showed robust lick activity 
(>400 licks per session). At the recording day, mice underwent the same sessions while 
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recording dLight1 fluorescence with fiber photometry. For analysis, mean fluorescence values 
were obtained from baseline (-10~-5 s from lick onset) and during consumption (0~5 s). 
 
Unpredictable footshock delivery  
Mice were placed into an operating chamber with a patch cord connected for photometric 
recordings. Five electric footshocks (0.6 mA for 1 second) were delivered with variable 
intervals (randomly chosen from uniform distribution between 45 and 75 seconds) without 
predictive cues. This was performed after all other experiments, since such aversive stimuli 
can induce sustained fear and anxiety to the context. For analysis, mean fluorescence values 
were obtained from baseline (-5~-1 s from lick onset) and during footshock (0~2 s). 
 
Cue-reward learning and extinction 
In cue-reward learning sessions, CS was turned on for 10 seconds and US was available 7 
seconds after CS onset, after variable inter-trial intervals (ITI). In cue-reward extinction sessions, 
same CS was turned on for 10 seconds without US delivery after variable ITI.  
In “expected reward delivery” trials, US was delivered after CS presentation, as in previous 
learning sessions.  
After sucrose consumption experiments, mice started appetitive Pavlovian 
conditioning, or cue-reward learning, in the same operant chamber. Conditioned stimuli (CS) 
consisted of house-light and 70 dB 5kHz tone, and were turned on for 10 seconds with 
variable intervals (randomly drawn from uniform distribution between 75 and 105 seconds). 
Unconditioned stimulus (US) was 50 µL of 5 % sucrose water, available at the 7th second 
after each CS onset. Pump sound from liquid dispenser was audible from 6th to 7th seconds. 
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CS-US pairings were repeated 20 times per session (therefore ~30 minutes for each session). 
Mice underwent total of 12 sessions for cue-reward learning. Chambers and lick port were 
sanitized with Accel and 70% ethanol between animals to remove any odor. For all sessions, 
lick data and photometry recordings were simultaneously obtained. Two to three days after 
the last cue-reward learning sessions mice began cue-reward extinction. Identical CS were 
given 30 times per session with variable intervals (between 45 and 75 seconds), now without 
US delivery. Mice underwent total of 5 extinction sessions. To quantify CS-triggered 
behavior, number of licks was counted during CS presentation. For photometry data, peak 
fluorescence was obtained for CS (0~3 s after CS onset) and US (-2~5 s around US 
consumption onset). US consumption onset for each trial was defined as the lick bout onset 
after US is available, where lick bout onset was detected with a threshold of 2 Hz. To examine 
fluorescence response shift from US to CS (or vice versa), we calculated CS-US index, 
defined as (CS response – US response) / (CS response + US response). 
 
Unexpected reward delivery and omission 
After 12 cue-reward learning sessions, mice underwent reward prediction error 
experiments. In “unexpected reward delivery” session, animals were exposed to normal CS-
US pairing trials; but in 25% of trials, US was delivered without CS, so that mice can explore 
to the lick port without predictive cues and consume reward in an unexpected manner. Peak 
fluorescence values after US consumption onset was obtained and compared between 
expected and unexpected conditions. In “unexpected reward omission” sessions, US delivery 
was omitted in 4 out of 20 trials (4th, 8th, 13th, and 16th trials) after predictive CS onset. For 
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analysis, mean fluorescence values were obtained from baseline (-10~0 s from CS onset) and 
after CS offset (10.5~11.5 s) and compared. 
 
Visuomotor learning task 
Prior to surgical preparation and behavioral training, mice were handled/tamed on two  
consecutive days to reduce stress during experiments. Following recovery from surgery (~7 
days) mice were water-restricted to 25 ml kg-1
 
per day and maintained at 80-85% of ad libitum 
weight. Training was performed in a custom-built setup that included a color LCD monitor 
(12.1" LCD Display Kit/500cd/VGA, ICP Deutschland GmbH) on which visual stimuli were 
presented. To reduce noise in optical recordings, the monitor was covered with a color filter 
(R342 Rose Pink, Rosco Laboratories Inc.). During training, mice were head-fixed with a 
custom-build head holder and placed on a spherical treadmill (Habitrail Mini Exercise Ball, 
Animal World Network) facing the LCD display. An optical encoder (E7P OEM, US Digital) 
attached to the treadmill allowed measurement of both speed and direction of ball movement. 
Water reward was delivered with a programmable syringe pump (NE-500 OEM Syringe Pump, 
New Era Pump Systems, Inc.). Behavioral signals were acquired through a data acquisition board 
(PCI-6221, National Instruments) connected to a breakout box (BNC-2110, National 
Instruments) and interfaced to MATLAB using the Data Acquisition Toolbox (Version 
R2010bSP2, The MathWorks Inc.). Behavioral task sequence was controlled by the MATLAB-
based software MonkeyLogic (www.monkeylogic.net) (56, 57). Custom-written functions were 
added to MonkeyLogic to enable analysis and control of ball rotation parameters. Treadmill 
encoder signals, trial marker codes (generated by MonkeyLogic), and imaging data were 
acquired in synchrony allowing running parameters, behavioral task events, and image frames to 
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be linked.  
Once the mouse stopped moving on the ball, a sequence of task events was initiated. 
First, a blue square frame was displayed on the monitor and required the animal to continue to 
stand still for a period of 10 s (ball rotation/velocity ≤ 2 mm/s). If the mouse continued to stand 
still for the entire stand-still phase, a second stimulus, a filled blue square, was presented for 3 s, 
instructing the mouse to initiate a run. If the mouse initiated sustained movement (ball 
rotation/velocity >10 mm/s for >1s duration) during the 3s stimulus phase, a water reward was 
delivered. In 20% of pseudo-randomly selected trials the reward was withheld (“Unexpected 
reward omissions”; light green traces in Fig. 5, fig. S15 and S16). If no running occurred, the 
trials counted as a miss trial. If the animal began to move during the 10 s stand-still phase (ball 
rotation/velocity > 2 mm/s), the trial was aborted and no water reward was delivered 
(“Spontaneous run trials”; pink traces). The mouse was able to initiate a new trial after an 
intertrial interval (ITI) of 5 s.  
During the first two days of training, mice spent ~15-30 min/day in the setup to become 
accustomed to head restraint. Mice were then trained daily for 60-90 min during which they 
performed ~300-700 trials. Task parameters were adjusted depending on individual animal’s 
performance. Initially, the duration of the stand-still phase was set to 3 s, the stimulus phase to 
20 s, and the running threshold to 2 mm/s. This increased the chance for the mouse to receive the 
task-dependent reward. The stand-still phase was then progressively extended and the stimulus 
phase shortened to establish the association between stimulus onset and running onset. Training 
continued until median reaction times (RT) had dropped below 1500 ms, which indicated that 
mice had learned to associate the visual cues with the desired behavior. Task proficiency was 
typically reached within 5-7 days. During the initial training phase all successful “Go” trials 
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were rewarded. Unexpected reward omission trials were introduced during imaging sessions 
only.  
 
In vivo optogenetic and pharmacological manipulations 
For optogenetic experiments, a patch cord (1 m length, 1.25 mm zirconia ferrule, 300 µm 
diameter fiber, Doric lenses) was used to connect to a ferrule on an animal’s head cap and a 
swivel commutator (fiber-optic rotary joints, Doric lenses) to allow free movement. Another 
patch cord was connected from the commutator and to a 635 nm diode-pumped solid-state 
laser (Changchun New Industries Optoelectronics Technology). The intensity of laser was 
measured with a power meter (PM100D, Thorlabs) and calibrated to be 10 mW at the fiber 
tip. An external TTL pulse generator (OTPG4, Doric Lenses) was used to control the laser 
output. For activating VTA DA neurons, 5 Hz, 10 Hz, and 20 Hz of 10 ms pulses were 
applied for 2 seconds. For activating VTA GABA neurons, 40 Hz pulses were used (58). 
These pulse trains were repeated 40 times per animal with intervals of 30 seconds. For 
pharmacological manipulations, the following drugs were used: DRD1 antagonist (SCH-
23390, 0.25 mg/kg) and selective DA reuptake inhibitor (GBR-12909, 10 mg/kg) (59). 
Animals were injected with these drugs or saline (0.9% sodium chloride) through 
intraperitoneal delivery 30 minutes before optogenetics/photometry experiments. Mean or 
peak fluorescence values were obtained before (-5~-1 s from onset), during (0.5~2 s) or after 
(4~10 s) photoactivation. 
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Data acquisition and analysis for ex vivo and in vivo imaging  
Ex vivo imaging in rat brain slice 
Imaging was carried out in a custom built 2-photon microscope. Data were acquired and 
collected using ScanImage software (60).  Slices were scanned at different frequencies, 
depending on the experiment, using 920 nm light. Electrical stimulation through a glass mono-
polar electrode placed within the slice near the area of imaging was used to evoke dopamine 
release. Experiments were carried out with a scan rate of 2 (128x128 pixels) or 15 (32x32 pixels) 
Hz. The fluorescence over the entire field (20x20 µm) was measured for each frame and plotted 
against time. Drugs were applied by superfusion. Line scans were taken at a 500 Hz frame rate. 
To measure the dopamine response curve, two-photon images were taken every minute. Image 
analysis was performed using custom software written in MATLAB.  
 
In vivo imaging in mouse dorsal striatum 
Treadmill velocity and acceleration were sampled at 1000Hz by a rotary encoder (E2-5000, 
US Digital) attached to the axle of the treadmill. Two-photon imaging was performed as 
described previously (61), using the same collection optics, but without the electric lens. 920 nm 
laser light was used for excitation and 1024x512 pixels time series datasets were acquired at 30 
Hz. Imaging sessions began after mice were acclimated to head fixation and ran frequently on 
the treadmill (~1-3 days). Imaging data was collected over 1-2 days from dorsal striatum fields 
ranging from 250 to 450µm in diameter.  All analyses were carried out using custom software 
written in MATLAB.  Time series movies were motion corrected on the static red channel using 
algorithms described previously (62) and x and y shifts from the red were used to correct the 
green channel.  Mean whole field fluorescence was calculated from a large, hand-selected ROI 
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containing all regions of the field with visible cellular structure in the red td-Tomato channel.  
Fluorescence time series were converted to ΔF/F by normalizing signals to an 8th percentile 
baseline (62) within a sliding window (+/-15s around each point) to correct for slow drift and 
bleaching.  Significant positive-going transients were calculated as previously described (62).  
 
In vivo imaging with fiber photometry 
Fiber photometry was performed as in (28, 63, 64). For dual color imaging a three LED 
system was used (FMC7, Doric Lenses): 490 nm for dLight1, 565 nm for jRGECO1a, and 405 
nm to be used as isosbestic wavelength for both indicators. The following dichroic filters and 
excitation/emission filters were used (all from Semrock): Di02-R405, Di02-R442, FF495-Di03, 
FF552-Di02, FF593-Di03, FF01-405/10, FF01-433/24, FF01-475/28, FF02-520/28, FF01-
565/24 and FF02-641/75 (28, 63, 64). Acquired photometry data were processed with custom-
written codes in MATLAB. Raw data from each channel were low-pass filtered at 25 Hz (for 
single color imaging) or 12 Hz (for dual color imaging) using a 2nd order Butterworth filter 
with zero-phase distortion. To calculate ΔF/F time series, a linear fit was applied to the 405 
nm signals and aligned to the 490 and 565 nm signals. The fitted 405 nm signal was 
subtracted from 490 and 565 nm channels, and then divided by the fitted 405 nm signal to 
yield ΔF/F values. Dual color imaging data were down-sampled to 100 Hz. In Pavlovian 
conditioning, ΔF/F time-series signal is further normalized using robust Z-score (subtraction 
of median and division by median absolute deviation, calculated from the entire session) to 
account for potential differences in signal variance across animals and sessions. Photometry 
signals were then extracted around relevant behavioral events (e.g. lick onset, footshock 
delivery, CS onset) and averaged. Power spectral density was estimated for averaged 
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dLight1/control sensor fluorescence data upon optogenetic stimulation of different 
frequencies. We used Welch’s method with 2-second window size and 50% overlap to 
estimate power from 0.5 to 25 Hz in 0.1 Hz step. 
 
In vivo two-photon imaging in the cortex.  
Once mice had reached proficiency on the task, they were imaged daily for up to 9 days. 
Imaging was performed using a resonant scanning two-photon microscope (Sutter Instrument) 
equipped with a pulsed femtosecond Ti:Sapphire laser (Chameleon Ultra II, Coherent). dLight1 
fluorescence was excited with 910 nm light, and detected using a ET525/70M emission filter 
(Chroma Technology Corp.) and H7422-40 GaAsP photomultiplier tube (Hamamatsu 
Photonics). Average excitation power was 40-130 mW depending on imaging depth and dLight1 
expression levels/duration. Typical recording depth was 80-150 µm below the pia. Data were 
acquired using a Nikon 16x 0.8-NA water immersion objective. A custom-made blackout curtain 
around the microscope’s detector was used to reduce light contamination by the LCD monitor. 
Images (512×512 pixels) were acquired at 30.8 frames/sec. Recording sessions consisted of five 
to twelve ~10 min recordings, separated by short imaging breaks (3-5 min). Recordings within a 
given session were performed at the exact same location to maximize the number of trial 
repetitions for analysis. Recordings from different sessions were performed at the same injection 
sites but offset either laterally or axially to maximize tissue volume being sampled.  
 
Analysis of cortical in vivo imaging data 
All data were analyzed using custom code written in MATLAB (MathWorks). Data from 
four animals were included in the analysis. Mouse #1 underwent 4 recording sessions starting 8 
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weeks after virus injection. Mouse #2 underwent 9 recording sessions starting 3 weeks after 
injection. Mouse #3 underwent 2 recording sessions starting 2 weeks after injection and Mouse 
#4 underwent 4 recording sessions starting 6 weeks after injection. Recording locations 
(M1/M2/FrA) are indicated in fig. S16E.  
To confirm the animals’ responsiveness to the “Go” stimulus, we compared proportions 
of trials in which runs were triggered by “Go” stimulus presentation (“Hit trials”) and 
proportions of trials in which no such response occurred (“Miss trials”) (fig. S16A and C). A 
steep increase in “Miss trials” at the end of the session indicated that mice had lost interest in the 
water reward. Trials beyond that point (black vertical line in fig. S16A) were excluded from 
analysis. To confirm that mice had learned the task, we analyzed the animals’ RTs (defined as 
the time interval between “Go” stimulus onset and movement onset/ball velocity >10 mm/s) (fig. 
S16B and D). RTs below 1500 ms indicated that mice had learned to associate the visual cues 
with the desired behavior.  
To reduce random noise in our time-lapse recordings a sliding average filter was applied 
(8 frames or 260 ms). This filtering largely retained the temporal dynamics of dLight1 
fluorescence signals. Lateral image motion (e.g., due to mouse movement) was corrected using a 
cross-correlation registration algorithm, with an average image of 50 consecutive frames from 
the time-lapse recording serving as the reference image. The same reference image was used to 
correct image motion of other recordings from the same location. Noise in motion-corrected 
image data was further reduced using a Kalman filter.  
To quantify/classify dLight1 transients, we tiled the field of view (FOV) with equally 
sized (~17x17µm) regions of interest (ROIs). To exclude ROIs with little or no dLight1 
expression (e.g., on blood vessels) we first generated a mean fluorescence projection image from 
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the corresponding time-lapse recording. We then calculated the projection image’s pixel intensity 
distribution. ROIs with mean pixel intensity values below the 55th
 
percentile of this distribution 
were excluded from analysis. To extract fluorescence time traces F(t) from all remaining ROIs, 
pixel intensities of each ROI were averaged. ΔF(t)/F was calculated as (F(t) – mean F) / mean F. 
ROIs that showed transients with negative amplitudes (predominantly located near blood 
vessels) were excluded from further analysis.  
Each ROI’s time trace included multiple trials/task repetitions. Based on the animal’s 
performance on the trials, time traces were subdivided into “Expected reward”, “Unexpected 
reward omission”, and “Spontaneous run” trial traces. This was done for all recordings from the 
same location using the same ROIs. Extracted trial traces were then sorted by trial type, aligned 
to running onset, and averaged (fig. S16G, single ROIs). To ensure that cued and spontaneous 
running bouts were comparable, only traces from spontaneous runs starting > 5 s after stand-still 
cue onset and with > 5 mm/s ball rotation/velocity were included. To calculate population 
responses, “Expected reward”, “Unexpected reward omission”, and “Spontaneous run” trial 
traces from all animals, all sessions, and all significant ROIs were averaged (Fig. 5E, group 
average).  
To identify ROIs with significant increases in dLight1 fluorescence in response to the 
task, three analysis intervals were defined (fig. S15A): (I) Baseline (from -7 to -2 s prior to run 
onset), (II) reward expectation (from run onset to 3.3 s after run onset), and (III) reward interval 
(from 4.3 s to 10.8 s after run onset). ΔF/F traces for each trial were averaged during the three 
trial intervals respectively. The distributions of the averaged ΔF/F traces for particular trial types 
were then statistically compared among each other and between intervals. ROIs that showed 
significant fluorescence increases during the reward expectation but not the reward interval, and 
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for all trial types compared to the baseline interval, were defined as “ROI active during 
locomotion” (white squares in Fig. 5 and fig. S16G). ROIs that showed significant fluorescence 
increases during the reward expectation but not reward interval for cued/triggered but not 
spontaneous run trials were classified as “ROI active during reward expectation” (black squares). 
Finally, ROIs that showed significant fluorescence increases during the reward interval for 
rewarded but not un-rewarded or spontaneous run trials were defined as “ROI active during 
reward” (red squares). Significance was determined using the Wilcoxon’s rank-sum test 
(p<0.05), Bonferroni corrected for multiple comparisons.  
All ROI analysis was performed on motion corrected image data (see above) averaged 
across trials of the same type and from the same session. To investigate whether this averaging 
introduces artifacts in the DA transients (e.g., due to stereotypic running-related image 
movements) we inspected our data more closely at cellular and population levels. Close 
observation of a 40x45 pixel detail of the motion corrected image data revealed stable and sharp 
images even during the most vigorous running periods (fig. S15A). Next, we plotted the full field 
of view (FOV) intensity changes for the average data of each trial type aligned at run onset (fig. 
S15B). This revealed that the main characteristics of the single ROI transients are retained in the 
full FOV average, arguing against a pronounced contamination by motion artifacts. Next, to 
investigate residual lateral shifts in the average image data for each trial type, we applied our 
motion correction algorithm. The detected residual image motion was <2 pixels for all sessions 
and mice (fig. S15C and D). To verify that our motion correction algorithm reliably detects sub- 
and supra-pixel image displacements we artificially introduced random lateral shifts of up to 5 
pixels to the same average image data (fig. S15E). The error between the introduced shifts and 
the shifts detected by the algorithm across 100 repetitions was 0.089 ± 0.001 pixels (mean ± 
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SEM). Together, this suggests that DA transients extracted from our 17x17µm ROIs are unlikely 
an artifact of image motion (fig. S15F).  
 
Histology 
Histological verification of proper sensor expression was as described previously (64). 
Primary antibodies used were: chicken anti-GFP (1:500; GFP-1020, Aves Labs), chicken anti-
TH (1:500; TYH, Aves Labs) and rabbit anti-RFP (1:500; 600-401-379, Rockland A&A).  
 
Hybrid chain reaction combined with immunohistochemistry 
       To assess the expression pattern of ChrimsonR-tdTomato injected into the VTA of 
VGAT::IRES-Cre mice, we performed combined in situ hybridization for labeling vgat mRNA 
and immunohistochemistry (IHC) for detecting DAergic neurons (with TH). To achieve high-
sensitivity in situ hybridization of vgat in tissue slices, we used hybridization chain reaction 
(HCR) (65, 66). First, we designed 22 probes for targeting vgat using a custom written software 
(available at https://github.com/GradinaruLab/HCRprobe). Each probe consists of 20-nt target 
sequence, 2-nt spacer, and 18-nt initiator. We selected the target sequences that has (1) the GC 
content of 45-60%, (2) no nucleotide repeats more than 3, (3) no more than 20 hits when blasted, 
(4) higher than a ΔG of -9 kcal/mol to avoid self-dimers. Then we blasted full sequences (target 
sequences with spacer and initiator) and calculate Smith-Waterman alignment scores between all 
possible pairs to exclude probes forming cross-dimers. The designed probes were synthesized by 
Integrated DNA Technologies. 
       HCR was performed on 50 µm-thick slices and kept in RNAlater solution (ThermoFisher 
Scientific). Slices were permeabilized in PBST (1xPBS with 0.1% Triton X-100) for 1 hour at 
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room temperature (RT) and pre-hybridized in hybridization buffer (2x saline-sodium citrate 
(SSC) , 10% ethylene carbonate, 10% dextran sulfate) for another hour at 37℃. Then the 
samples were incubated in pre-warmed hybridization buffer including probes (2 nM for each) at 
37℃	overnight. After hybridization, we performed stringent washes with wash buffer (2xSSC, 
10% ethylene carbonate) for 30 min at 37℃ and washes with 2xSSC for 30 min at RT (twice for 
each). The amplification step was performed as described in (67) overnight.  
       For IHC labeling of TH on HCR-labeled tissue slices, we used IHC buffer consisting of 
2xSSC, 1% donkey serum, and 0.1% Triton X-100. We incubated the samples in IHC buffer for 
1 hour at RT for blocking and added primary antibody (anti-TH, AB152, Millipore, 1:200). 
Primary antibody reaction was performed for overnight at RT. Following the wash steps with 
2xSSC at RT for 30 min twice, the samples were incubated in IHC buffer including secondary 
antibodies (1:200) for overnight at RT. The samples were rinsed with 2xSSC a few times and 
mounted on a glass slide with mounting media (Prolong Diamond, ThermoFisher Scientific). 
 
Probe sequences (5’->3’) 
 
1 CACTTCATATCACTCACTaaGACACGGAGGTGGCCACATT 
2 CACTTCATATCACTCACTaaGCGATGCTCAAAGTCGAGAT 
3 CACTTCATATCACTCACTaaCCTGAATGGCATTTGTCACG 
4 CACTTCATATCACTCACTaaACCAGGACTTCTGCGACACG 
5 CACTTCATATCACTCACTaaTTCTTCAGGAAGGCGCAGGG 
6 CACTTCATATCACTCACTaaTTCTCCCAGGCCCAATCACG 
7 CACTTCATATCACTCACTaaGTGTAGCTGAACACGATGAT 
8 CACTTCATATCACTCACTaaGCGGCGATGTGTGTCCAGTT 
9 CACTTCATATCACTCACTaaACTTCCTTGGTCTCGTCGGC 
10 CACTTCATATCACTCACTaaCGCGAAGAAGGGCAACGGAT 
11 CACTTCATATCACTCACTaaAGGCGCAAGTGGAAGAGGCT 
12 CCTTGGCCTGGGACTTGTTGaaCCCAATCTCTATCTACCC 
13 ATGTCCATCTGCAGGCCCTGaaCCCAATCTCTATCTACCC 
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14 TAGGCCCAGCACGAACATGCaaCCCAATCTCTATCTACCC 
15 CACCGCTGTGGCTATGATGGaaCCCAATCTCTATCTACCC 
16 ACTTGGACACGGCCTTGAGAaaCCCAATCTCTATCTACCC 
17 CGTCGATGTAGAACTTCACCaaCCCAATCTCTATCTACCC 
18 AGGGCAGGAAGATCTGCGACaaCCCAATCTCTATCTACCC 
19 AGAGACCCTTGAGCACGCAGaaCCCAATCTCTATCTACCC 
20 CGGGCAGGTTATCCGTGATGaaCCCAATCTCTATCTACCC 
21 TTCTCCAGCACTTCGACGGCaaCCCAATCTCTATCTACCC 
22 ACAGCAGCTTGCGCCAGAGAaaCCCAATCTCTATCTACCC 
 
Statistical Analysis 
All statistical analyses were performed in MATLAB (MathWorks), Igor Pro (WaveMetrics) 
or Prism (GraphPad). We used both parametric (t-test, one-way ANOVA, two-way ANOVA) 
and non-parametric (Wilcoxon’s rank-sum) tests. Pearson’s correlation coefficients and their p-
values were calculated to assess how behavior or dLight1 fluorescence evolved across reward 
learning or extinction. All tests were two-tailed. Error bars are standard error of the mean or 
standard deviation as indicated in figure legends and main text. No statistical methods were used 
to predetermine sample size.  
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Fig. S1.  Screening dLight1 variants. (A) Membrane expression and response of original dopamine sensor built by 
inserting the original GCaMP6 cpGFP module (LSS-LE-cpGF-LP-DQL) into DRD1. Peak response (-19.4 ± 0.02 % 
∆F/F, mean ± SEM, n=12 cells). Inset shows membrane intensity profile. Scale bar, 10 µm. (B) Resting fluorescence for 
all screened variants that showed expression. Proportion of response type in horizontal bar. Color-coding indicates 
significance value (n=3). (C-G) Optimizing insertion site of cpGFP in DRD1. (C) Sequence alignment of DRD1 and β2 
adrenergic receptor encompassing TM5-TM6 (replacement sites was indicated as 0 aa in each TM region) is shown. (D, 
E) Representative images showing membrane expression of dLight1 variants. Scale bar, 10 µm. (F) Quantification of 
∆F/F and surface expression from variants shown in D. ΔF/F: -3 aa, 70.1 ± 10.8 %; -2 aa, -1.3 ± 6.7 %; -1 aa, 199.4 ± 
13.1 %; 0 aa, 223.2 ± 8.2 %; +1 aa, 652.3 ± 9.8 %. Surface expression values quantified in arbitrary units and 
normalized to 0 aa control (-3 aa, 33.6 ± 4 %; -2 aa, 30 ± 1.8 %; -1 aa, 88.8 ± 6.4 %; +1 aa, 87 ± 2.7 %). (G) 
Quantification of fluorescent signal changes and surface expression from variants shown in e. ΔF/F values: -2 aa, -9.2 ± 
2.3 %; 0 aa, 223.2 ± 8.2 %; +2 aa, 205 ± 21 %). Surface expression values quantified in arbitrary units and normalized 
to 0 aa control: -2 aa, 36.4 ± 2.9 %; +2 aa, 25.9 ± 0.86 %. All values are shown as mean ± SEM. *p<0.05, **p<0.01, 
****p<0.0001 versus 0 aa position control, One-way ANOVA with Dunnett’s post-hoc test. 
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Fig. S2. Characterization of dLight1.3a and dLight1.5. (A) Top, aminoacid sequence of DRD2 insertion site for the 
cpGFP module. Bottom, representative images of dLight1.3a and dLight1.5 expressed on HEK293 cells before and after 
addition of DA (10 µM) and corresponding SNR heatmaps. Scale bars, 10 µm. (B) Quantification of fluorescence 
response of dLight1.3a (n=12) and dLight1.5 (n=4) to DA titrations on HEK293 cells. Data were fit with Hill equation 
(EC50: dLight1.3a, 2300 ± 20 nM; dLight1.5, 110 ± 10 nM). (C) Representative images of dLight1.5 under basal 
conditions, after addition of quinpirole (10 µM) and haloperidol (50 µM), and trace showing quantification of 
fluorescence response during bath application of drugs (n=15). All data are shown as mean ± SEM. 
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Fig. S3. One photon emission spectrum and two-photon cross-section of dLight1 expressed in HEK293T cells. 
Emission spectrum of both dLight1.1 and dLight1.2 peaks at 517 nm. Under 2P illumination, emission peaks are driven 
at 920 nm.  
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Fig. S4. Characterization of dLight1 in cultured hippocampal neurons and organotypic hippocampal slice. (A) 
Representative images showing membrane localization of dLight1.1 (GFP fluorescence in green, Alexa-564-conjugated anti-flag 
labeling in red) in cultured hippocampal neurons. Inset shows membrane intensity profile. (B) dLight1.1 and dLight1.2 responses 
to dopamine perfusion, which were abolished immediately with the addition of a DRD1 antagonist (mean ± SEM, n=4 sessions). 
(C) In situ titration on neurons (mean ± SEM, n=7 cells). Fitted with Hill equation (EC50: dLight1.1, 311 ± 26 nM; dLight1.2, 
1,157 ± 44 nM). (D) Representative images showing uncaging spots (purple circle, 2 µm diameter, 40% laser power 405 nm light). 
Scale bar, 5 µm. (E) Representative traces of dLight1.2 fluorescence in response to increasing duration of uncaging light pulses 
(1ms per pulse). (F) Quantification of peak ΔF/F values which is correlated with the number of uncaging pulses (1 ms, 2.7 ± 0.01 
%; 2 ms, 8.2 ± 2.2 %; 5 ms, 18.9 ± 3.9; 10 ms, 32.8 ± 2.5; 20 ms, 58.4 ± 5.3; 50 ms, 83.4 ± 7.8; 100 ms, 91.1 ± 6 %; n=3, mean ± 
s.d.). (G) Representative dLight1.2 responses to bath applied DA from sparsely-labeled CA1 pyramidal neurons in organotypic 
slice cultures. mCherry expression was used as a cell fill to visualize dendritic and synaptic structures (shown in rectangular and 
circular boxes, respectively) and to provide reference fluorescence. (H-I) Quantification of both green and red (control) 
fluorescence signal change at single spines and dendrites in response to a titration of DA concentrations. Maximal ΔF/F% fold 
change in the green channel were: synaptic spines, 227 ± 39; dendrites 201 ± 46 (mean ± s.d., n=5). EC50 values were: spines, 844 
nM; dendrites, 883 nM. 
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Fig. S5. Specificity of dLight1.  Specificity of dLight1 response was determined by titrations of a panel of 8 different 
neuromodulators on dLight1.1-expressing HEK293 cells. Acetylcholine, ACH; histamine, HIS; γ-aminobutyric acid, 
GABA; serotonin, SER; octopamine, OCT; epinephrine, EPI; norepinephrine, NE; dopamine, DA. Kd values for DA, 
NE and EPI were: 330 ± 28 nM, 19,850 ± 2,644 nM, 12,680 ± 1,559 nM, respectively. Results shown as mean ± SEM, 
(n=3). 
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Fig. S6. Functional analysis of dLight1 signaling properties. (A) cAMP response curve to a titration of DA in 
HEK293T cells expressing wild-type human DRD1 receptor or dLight1.1 or dLight1.2 or GFP. No significant cAMP 
response were observed in cells expression dLight1.1 (n=3, **p<0.01, ***p<0.001, one-way ANOVA, Dunnett’s post 
test). (B) cAMP response curves of  a cell line endogenously expressing DRD1 (U2OS).  Overexpression of dLight1.1 
did not alter the cAMP response to DA (n=3, p=0.192, two-way ANOVA with Tukey’s post-hoc test. (C) dLight1.1 
internalization is significantly reduced compared to wild type DRD1 as assayed via flow cytometry (% internalized 
receptor: dLight1.1, 3.4 ± 0.5 %; DRD1, 14.3 ± 1.9 %; **p<0.01, unpaired t test). (D) TIRF microscopy visualization of 
dLight1.1 shows the fluorescent response to a DRD1 agonist (SKF81297) in green channel but not in red channel, 
which was immediately abolished by applying antagonist (SCH23390). (E) In situ surface staining with an Alexa-647 
conjugated anti-flag antibody further confirmed the lack of internalized punctae. (F) Quantification of fluorescence 
responses in (D) and (E).   
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Fig. S7. Versatility of engineering approach to generate other GPCR-sensors. (A) Left, aligned sequences of TM 5 
and TM6 from 7 GPCRs with insertion site for cpGFP module. To maximize ∆F/F in the B2AR and MT2 constructs the 
“QLQKID” sequence was inserted between TM5 (after the last R) and before LSS. Scale bars: 10 µm. Right, SNR 
heatmaps for a subset of GPCR sensors expressed in HEK cells. (B) Quantification of fluorescence response and 
membrane expression for each GPCR-sensor construct. Max ∆F/F of each sensor to bath applied agonist (B1AR: 70 ± 
4%, n=8; B2AR: 149 ± 7%, n=9; A2AR: 77 ± 8%, n=11; KOR: 60 ± 4%, n=8; MOR: 37 ± 2%, n=10; 5HT2A: 40 ± 3%, 
n=12; MT2: 38 ± 3%, n=8). Agonists used were: norepinephrine for B1AR, B2AR, A2AR (100 µM); U50488 for KOR 
(10 µM); [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO) for MOR (10 µM); serotonin for 5HT2A (10 µM); 
melatonin for MT2 (10 µM). Membrane expression was calculated as membrane-to-cytosol ratio and normalized to 
dLight1.1 (B1AR, 102 ± 4%; B2AR, 86 ± 6%; DRD2, 39 ± 4%; A2AR, 36 ± 4%, KOR, 45 ± 3%; MOR, 19 ± 1%; 
5HT2A, 70 ± 3%; MT2, 24 ± 1%; n=6). Individual datapoints are shown. mean ± SEM shown in black. 
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Fig. S8. Characterization of dLight1 performance in striatal brain slice. (A-C) Spatially-distinct responses triggered by 
electrical stimuli in acute rat striatum slice. (A) Representative field of view for two-photon imaging of acute striatum slice 
infected with AAV9.hSynapsin1.dLight1.2. (B) ROIs hierarchically clustered based on correlations in the time course of their 
fluorescence values. (C) ROIs location relative to (A), with color-coding corresponding to the dendrograms from the hierarchical 
clustering. (D) A steady-state concentration response curve with bath application of specified DA concentrations in the presence of 
cocaine (10 µM) and sulpiride (400 µM) to block D2-autoreceptors. The increase in fluorescence to each known concentration of 
DA (1-100 µM) was measured after reaching a steady level in 3-10 min. (E) Quantification of concentration-dependent 
fluorescence responses from (D). The fluorescence response reached half-maximal levels at about 5 µM DA and approached 
saturation at 30-100 µM. Curve was fitted with a Hill equation (EC50 = 5.3 ± 0.4 µM; mean ± s.d.; n=3). (F) Fluorescence 
response to a single-pulse stimulation in the presence of amphetamine (10uM) or the DRD1 antagonist SKF83566 (1 µM). (G) 
Estimate of basal DA concentration in the presence of amphetamine at saturated concentration by interpolation on a dose-response 
curve, normalized to peak value (n numbers are shown for each concentration).  
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Fig. S9. Two photon imaging of locomotion related bi-directional dopamine transients in dorsal striatum. (A) Schematics of 
two-photon imaging of head-fixed mouse during treadmill locomotion. (B) Mean fluorescence projection from a representative 
imaging field showing green dLight1.1 expression (top) and red td-Tomato expression (bottom). (C) Average fluorescence changes 
in the field of whole in green (ΔF/F, green, top), red fluorescence (magenta, center), and treadmill velocity (black, bottom) for a 
representative imaging session. (D-E) Mean ΔF/F traces for 16 equal-sized ROIs tiling the imaging field pictured in (C) (red-
dashed lines) in green and red. Note large positive-going transients and the high synchrony across ROIs in dLight1.1 fluorescence, 
but not in td-Tomato fluorescence. (F) Mean ΔF/F for all significant positive-going transients in mice expressing either dLight1.1 
(n = 2 mice, 131 transients) or dLight1.2 (n = 2 mice, 31 transients). (G-H) Mean transient ΔF/F during rest and run for all fields in 
dLight1.1 (n = 2 mice, 5 fields) and dLight1.2 (n = 2 mice, 8 fields) (I) Cross correlation between acceleration and ΔF/F for 
dLight1.1 during run periods (peak mean cross correlation 240ms). (J-L) DA transients were rapidly and bi-directionally 
modulated by accelerations and decelerations. Mean ΔF/F from dLight1.1 aligned on the zero crossing of all large accelerations (J) 
or decelerations (K). Note the significant peak in ΔF/F following the acceleration peak (J) or the decrease below baseline 
following decelerations (K). (L) Same as (J, K) but for the td-Tomato traces. Note the lack of significant peaks or troughs to 
accelerations or decelerations. Shaded regions and error bars indicate SEM. Asterisks indicate p< 0.0001 with Wilcoxon rank-sum 
test. 
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Fig. S10. Fiber photometry setups and spontaneous DA transients in NAc. (A) Schematics of fiber photometry 
setup for dLight1 imaging. Two LEDs were used: 490 nm for dLight1.1 excitation and 405 nm for an isosbestic 
wavelength (63). These two LEDs were modulated at different frequencies and demodulated with lock-in functions 
implemented in the custom software. (B) Schematics of “dual color” fiber photometry setup. Compared to conventional 
fiber photometry, an additional 565 nm LED was added to excite red-shifted Ca2+ indicator jRGECO1a (31). Emitted 
fluorescence was divided into three channels based on their spectral profiles, detected by separate photoreceivers and 
then demodulated. (C) Representative traces of dLight1.1 (green) and control sensor (gray). Note that there are clear 
fluctuations of fluorescence in dLight1.1 with occasional bursts, while no apparent change of fluorescence is observed 
with control sensor. 
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Fig. S11. Histological verification of fiber tip locations during fiber photometry recordings. (A) Histologically 
verified anatomical positions of implanted fibers for photometry in the NAc. (B) Histologically verified anatomical 
positions of implanted fibers for optogenetic stimulation in the VTA. Histological brain images were reproduced from 
Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates (Academic Press, 2012). 
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Fig. S12. Histological verification of virus expression in the NAc and VTA. (A) Histological image of dLight1.1 (green) 
expression in the NAc with fiber tip location in a VGAT-Cre mouse. Blue indicates nuclear staining DAPI. (B) Histological images 
showing that ChrimsonR-expressing (magenta) neurons do not overlap with DA (green for tyrosine hydroxylase (TH)+) neurons in 
the VTA. (C) Histological images showing that ChrimsonR-expressing (magenta) neurons in the VTA co-localize with vgat 
mRNA (green, detected by hybrid chain reaction in situ hybridization, see supplementary information for details), but not with TH 
protein (blue, by IHC). Thick arrows indicate neurons co-expressing ChrimsonR and vgat mRNA. (D) Representative low-
magnification images of VTA regions in TH-Cre mice showing optical fiber tip locations (best visible in DAPI section) and virus 
expressions in the VTA. Blue is DAPI, green TH+ DA neurons, and magenta ChrimsonR+ neurons. (E) Same as (D) above, but for 
a VGAT-Cre mice. (F) Histological images of a NAc region with co-expression of dLight1.1 (green) and jRGECO1a (magenta).   
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Fig. S13. dLight1 fluorescence in response to optogenetic stimulation of VTA DA or GABA neurons and NAc DA dynamics 
underlying natural behaviors. (A) Magnified version of traces in Fig. 3D. Note that there are clear peaks of DA transients 
corresponding to each optogenetic stimulation pulses, even at 20 Hz. (B) Power spectral density analysis reveals peaks at matching 
stimulation frequencies (and harmonics) in dLight1.1, while the control sensor shows no clear peak in any frequency ranges. (C) 
Raw trace of a TH-Cre mouse expressing dLight1.1 during VTA DA photostimulation. Optogenetic stimulation of VTA DA 
neurons caused evident and time-locked increase in fluorescence from spontaneously fluctuating transients. (D) Raw trace of a 
VGAT-Cre mouse expressing dLight1.1 during VTA GABA photostimulation. Fluorescence is decreased from baseline 
fluctuations upon optogenetic stimulation of VTA GABA neurons. (E) DA dynamics during natural behavior recorded from 
conventional fiber photometry with separate mouse cohort expressing dLight1.1 alone in the NAc. Mice consumed 5% sucrose 
water. Consistent with dual color fiber photometry results shown in Fig 3M and voluntary reward consumption was associated 
with increase of dLight1.1 fluorescence (mean fluorescence increase was quantified; paired t-test, t4 = 8.495, p = 0.0011). (F) DA 
dynamics while mice expressing dLight1.1 only in the NAc received unpredictable footshocks. Footshock caused transient 
depression of dLight1.1 fluorescence, which is consistent with dual color fiber photometry results shown in Fig 3O (mean 
fluorescence decrease were quantified; paired t-test, t4 = 3.765, p = 0.0197).  
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Fig. S14. Detection of US consumption onsets and details of DA dynamics after learning. (A) Individual trial heatmap data of 
lick rate (top) and fluorescence (bottom) from a mouse in learning session 1. Notice that lick onsets (indicated as magenta triangles 
or sudden color change from blue to yellow) are highly variable in this early session. When fluorescence is averaged from CS 
onset, fluorescence response from US is averaged or canceled out. However, when fluorescence is averaged from US consumption 
onset (defined as lick onset after US is available), fluorescence peaks are aligned and results in higher US response. (B) Same as 
(A), but from learning session 12. After cue-reward association, mice show anticipatory lick behaviors in most of trials, therefore 
most lick onsets correspond to the time when US is available (t = 7 s after CS onset or second dotted line). Therefore, US response 
values are almost identical when fluorescence are averaged from CS onset or US consumption onset. (C) Averaged photometry 
traces from learning sessions 1, 2, 5, and 12. We observed total of four peaks in dLight1 fluorescence (best visible at the session 5): 
1) CS-evoked (right after time = 0, which was dynamically modulated across learning and extinction), 2) pump sound induced 
(after time = 6), 3) US-evoked (after time = 7) and 4) CS termination induced (after time = 10) peaks. (D) CS-US index (see 
supplementary information for definition) increases across learning sessions, suggesting that fluorescence response is transferred 
from US to CS. (E) Positive correlations between CS peak fluorescence and licks during CS presentation, both in learning (left) 
and extinction (right) sessions. 
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Fig. S15. Cortical dLight1 transients during animal behavior cannot be explained by image motion artifacts. (A) Top, 
average mouse running velocity for rewarded “Hit trials” from an example recording session. Data were aligned to running onset 
(vertical black line) prior to averaging. Three time intervals are indicated: “(I) Baseline interval” is part of the interval during 
which the animal was required to stand still; “(II) Reward expectation interval” defines the interval during which the mouse began 
to run and expected a reward; and “(III) Reward interval” defines the period during which the water reward was delivered in 80% 
of “Hit trials”. Bottom, 40x45 pixel detail from the corresponding time-lapse fluorescence imaging data. Image data was motion 
corrected prior to averaging (Methods). Image comparison (dotted crosshair) indicates that residual image movement was below 
one pixel within and across the baseline, reward expectation, and reward intervals. (B) Top, average mouse running velocity from 
the same recording session but for all trial types. Bottom, corresponding dLight1.2 fluorescence transients across the entire field of 
view (FOV). Data was motion corrected prior to averaging. Full FOV transients retain the main characteristics of the single ROI 
transients (Fig. 5E), but details about the spatio-temporal heterogeneity of DA release are lost. (C) Lateral image displacements 
detected by the motion correction algorithm for the example average data shown in panel B. Image displacements were below one 
pixel for all trial types. (D) Maximum lateral image displacements for all averaged recording sessions and all mice. Error bars 
indicate SEM. (E) The motion correction algorithm reliably detected sub- and supra-pixel image displacements. Artificially 
introduced shifts (grey) to the data shown in panels A-C were tracked by the algorithm with sub-pixel precision (black). (F) Top, 
task-related dLight1.2 fluorescence transients plotted as intensity average from an example ROI (from fig. S16G). Bottom, 
transients extracted from the same ROI when applied to an artificially generated dataset in which the first frame of the top panel 
dataset was displaced using the lateral residual shifts shown in panel C. Intensity average transients produced by image shifts to the 
static first frame are negligibly small and distinct from task-related fluorescence transients.  
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Fig. S16. Behavioral performance and single-session dLight1 transients during cortical two-photon imaging. (A- D) Mouse 
performance on the visuomotor association task during imaging sessions. (A) Example performance data from one recording 
session. Out of all trials in which the “Go” stimulus was presented, the proportion of “Hit trials” (green) was >80%. The “Go” 
stimulus was not presented in “Spontaneous runs” (pink) during the stand-still phase. Animals typically performed the task 
successfully for several hundred trials before a steep increase in “Miss trials” (yellow) indicated that they had lost interest in the 
water reward. Trials beyond that point (black vertical line) were excluded from analysis. (B) Reaction times (RT) from an example 
recording session. Most “Go” stimulus-triggered runs happened within the first second after stimulus onset indicating that the 
mouse had learned the task. The dashed line at 13s indicates the “Go” stimulus offset. (C) Population data showing mean 
proportion of “Hit trials” for all mice (N=4) and recording sessions (mouse #1: 4 sessions; mouse #2: 9 sessions; mouse #3: 2 
sessions; mouse #4: 4 sessions). (D) Mean RTs for all mice and recording sessions. Error bars in panel C and D indicate SEM. (E) 
Dorsal view of the mouse cortex with the imaging locations (square) from all mice indicated. (F) Example fluorescence image 
details showing dLight1.2 expression pattern for different mice and recording locations: M1 cortex, layer 1 and layer 2/3; FrA 
cortex, layer 2/3. The computationally defined regions of interest (ROIs), colored based on their response type, are overlaid. 
Single-session fluorescence transients of the highlighted ROIs (bold outlines) are shown in panel G. (G) Representative task-
related dLight1.2 fluorescence transients from example recording sessions (population averages are shown in Fig. 5E). Top, mouse 
running speed on the spherical treadmill. Bottom, three common types of task-related fluorescence transients in M1. Left, example 
ROI showing significantly increased dLight1.2 fluorescence during locomotion but not reward; middle, ROI significantly active 
during reward expectation but not locomotion; right, ROI with significantly increased dLight1.2 fluorescence during the reward. 
Each colored trace is an average of the indicated number of trials aligned to running onset (vertical black line). p<0.05, Wilcoxon 
test, Bonferroni corrected for multiple comparisons. (H) Population data showing the number of ROIs with significant dLight 
transients in layer 1 (L1) and layer 2/3 (L2/3) of area M1 sorted by the three response types (see panel G and Fig. 5E). 
Significantly more reward related responses are seen in deeper layers. * indicates significance, Binomial test, p<0.05, adjusted for 
total number of ROIs recorded in the respective layer. 
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Data S1. (separate file) 
Sequences of the constructs used in this study. 
Data S2. (separate file) 
Data info for Figure 1-2. 
Data S3. (separate file) 
Data info for Figure 5. 
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